Custom Protein Production for Antibody Development
Custom protein production for antibody development provides a target-specific recombinant antigen when a catalog protein does not match the required sequence, construct, expression system, tag, purity or formulation. Beta LifeScience supports catalog, semi-custom and fully custom protein production, with the option to coordinate antigen preparation with monoclonal or polyclonal antibody development. Researchers can request a full-length protein, selected domain, mutant, isoform or specialized membrane-associated antigen according to the intended antibody application.
Request a Custom Protein Quote | Discuss Your Antigen Design

How Can a Custom Protein Support Antibody Development?
Depending on the project, a custom recombinant protein can support:
- Animal immunization
- Antibody screening
- Specificity testing
- Antigen-affinity purification
- ELISA assay development
- Western blot controls
- Binding studies
- Functional validation
The protein can be customized according to the target species, sequence, construct boundaries, expression host, purification tag, purity, endotoxin level, buffer, formulation and required quantity. Direct answer: The best custom antigen is a stable and sufficiently pure protein that presents the required target epitope in a format relevant to the final antibody application.
Catalog, Semi-Custom or Fully Custom Protein?
A completely new production workflow may not be required when an existing recombinant protein already meets the project specifications. Researchers should compare available purchasing routes before requesting development.
|
Production option |
Best suited for |
Starting point |
Customization |
Action |
|
Catalog protein |
Standard targets and established constructs |
Available product |
Existing specifications |
|
|
Semi-custom protein |
Existing protein requiring a different tag, buffer, endotoxin level or packaging format |
Established production platform |
Selected modifications |
|
|
Fully custom protein |
Novel sequence, mutant, isoform, uncommon species or specialized construct |
Customer sequence or target information |
Extensive customization |
|
|
Integrated protein and antibody project |
Researchers requiring both antigen preparation and antibody generation |
Target and application requirements |
Coordinated protein and antibody services |
Choose a catalog protein when its sequence, species, host, tag and formulation already fit the study. Semi-custom production is suitable when an established protein needs selected modifications. Fully custom production provides greater control over novel or application-specific antigens.

Why Choose Beta LifeScience?
The available services support researchers who require more flexibility than a standard catalog product can provide.
Multiple protein-expression platforms
Available production platforms include bacterial, yeast, insect and mammalian expression systems. The host can be selected according to the target’s folding, post-translational modification, solubility and scale requirements.
Catalog, semi-custom and fully custom routes
Researchers can begin with an existing recombinant protein, request selected modifications through semi-custom production or submit a new construct for fully custom expression.
Integrated protein and antibody production
Beta LifeScience can coordinate recombinant antigen preparation with monoclonal or polyclonal antibody development. This creates continuity between antigen design, protein production, immunization and project-specific screening.
Conventional and membrane-associated targets
Soluble proteins, extracellular domains, functional domains and other conventional constructs can be evaluated. A dedicated transmembrane protein expression service is also available for complex membrane-associated targets.
Customizable protein specifications
Project specifications may include:
- Construct boundaries
- Expression system
- Tag type and position
- Tag-removal strategy
- Purity target
- Endotoxin requirement
- Buffer and concentration
- Liquid or lyophilized formulation
- Packaging format
- Production quantity
Project-specific quality control
Quality-control methods and acceptance criteria can be defined during quotation. Researchers should confirm which purity, identity, endotoxin or functional analyses will be included before production starts.
Technical feasibility review
The target sequence and project requirements are reviewed before the final scope, confirmed timeline and quotation are prepared. This helps match the production strategy to the intended antibody application.
Scale-up and repeat production
Protein expression and purification can support small-scale research and larger production requirements. Buyers planning long-term studies can discuss scale-up, repeat batches, lot requirements and packaging during project evaluation.
Submit Your Target for Feasibility Review
Select the Right Antigen Format
|
Antigen format |
Suitable antibody goal |
Main selection consideration |
|
Full-length protein |
Broad epitope coverage |
Folding, size and solubility |
|
Extracellular domain |
Cell-surface receptor antibodies |
Native-like domain structure |
|
Functional domain |
Antibodies against a defined region |
Stable construct boundaries |
|
Truncated protein |
Soluble production of a challenging target |
Retention of the required epitope |
|
Mutant or isoform |
Variant-specific antibodies |
Unique sequence and suitable controls |
|
Fusion protein |
Improved expression or purification |
Potential immune response to the tag |
|
Membrane-protein format |
Conformational membrane-target recognition |
Epitope presentation and stabilization |
Full-length protein or selected domain?
A full-length protein presents multiple potential epitopes and may be suitable when broad target recognition is required. A selected domain can focus the immune response on an extracellular, functional or application-relevant region. For large, multidomain or poorly soluble targets, a carefully selected domain may provide a more practical antigen. Construct boundaries should preserve the intended epitope while supporting protein stability.
Mutants and isoforms
Custom production can support antibodies against disease-associated mutations, splice isoforms or species-specific sequences. Include related wild-type or alternative-isoform proteins in the screening plan when target discrimination is important.
Membrane-associated targets
Membrane proteins may require an extracellular domain, cell-based antigen or specialized presentation format. The preferred approach depends on whether the antibody should recognize a linear sequence, folded domain or native membrane-associated conformation.

Choose the Appropriate Expression System
Expression-system selection influences folding, post-translational modifications, production yield and scalability.
|
Expression system |
Key production advantage |
Commonly considered for |
|
E. coli |
Efficient expression and straightforward scale-up |
Non-glycosylated proteins, intracellular targets and soluble domains |
|
Yeast |
Scalable eukaryotic expression |
Secreted proteins and selected eukaryotic antigens |
|
Insect cells |
Supports complex folding and several modifications |
Multidomain proteins and complex antigens |
|
HEK293 cells |
Mammalian folding and processing |
Secreted proteins, receptors and extracellular domains |
|
CHO cells |
Mammalian expression with scale-up potential |
Complex glycoproteins and larger production requirements |
An E. coli platform can suit proteins that do not require complex mammalian processing. Mammalian expression is often selected when folding, disulfide bonding or glycosylation contributes to the required epitope. Yeast and insect-cell systems provide additional production routes for selected eukaryotic proteins. The final recommendation should be based on sequence analysis, application and production requirements.
Researchers can review the protein expression host-selection guide or request a technical recommendation.

Select a Suitable Purification Tag
Tags can support protein expression, purification, detection and immobilization.
|
Tag option |
Potential use |
|
His tag |
Affinity purification and routine detection |
|
GST tag |
Purification and possible solubility support |
|
Fc tag |
Dimerization and protein A/G purification |
|
AviTag |
Site-specific biotinylation and controlled immobilization |
|
FLAG or HA |
Established detection workflows |
|
Tag-free protein |
Reducing tag-related responses during immunization |
Depending on the project, the tag can be removed before immunization or different tags can be used during immunization and screening. Review the protein tag-selection guide when comparing tag types, positions and cleavage options.
Define Purity, Endotoxin and Formulation Requirements
Specifications should be selected according to how the antigen will be used.
Protein purity
Purity requirements may differ between immunization, screening, affinity purification and functional testing. The requested purity target and analytical method should be included in the project proposal.
Endotoxin level
Endotoxin control can be important for proteins produced in bacterial systems and used in sensitive cell-based or in vivo applications. Request a defined endotoxin specification and testing report when the downstream workflow requires them.
Existing targets may also be available through the ultra-low endotoxin recombinant protein collection.
Buffer and formulation
The formulation should remain compatible with immunization, conjugation, immobilization, screening or storage requirements. Available options can be discussed for:
- Buffer composition
- Protein concentration
- Stabilizing additives
- Liquid or lyophilized format
- Small aliquots
- Bulk packaging
Share any buffer restrictions during feasibility review, especially when the protein will be used with a particular adjuvant, conjugation method or assay surface.

Match the Antigen to the Antibody Application
The final antibody application should influence construct and antigen selection.
|
Final application |
Antigen-selection priority |
|
ELISA |
Purified, stable protein with accessible epitopes |
|
Western blot |
Recognition of linear or denatured epitopes |
|
Flow cytometry |
Native extracellular or membrane-associated presentation |
|
Immunohistochemistry |
Epitopes retained following fixation and processing |
|
Immunofluorescence |
Relevant cellular structure and fixation compatibility |
|
Immunoprecipitation |
Accessible epitopes in folded proteins or complexes |
|
Neutralization |
Native structure and functionally relevant epitopes |
|
Affinity purification |
Stable immobilization with the target epitope available |
A protein format suitable for Western blot antibody development may not be ideal for flow cytometry or neutralization. Sharing the intended application during feasibility review supports a more relevant construct and screening plan.

Custom Protein Production Workflow
The Beta LifeScience custom production workflow begins with a technical review and progresses through expression, purification, quality control and delivery.
1. Submit the target
Provide the protein name, species, accession number or sequence. Include the required construct and intended antibody application where available.
2. Complete a feasibility review
The technical team evaluates construct design, expression host, purification tag, expected quantity and quality requirements.
3. Review the proposal and quotation
The project proposal defines the agreed scope, specifications, potential deliverables, quality-control methods, pricing and confirmed timeline.
4. Begin protein expression and purification
The approved construct is prepared for the selected host, expressed and purified according to the agreed workflow.
5. Complete quality-control evaluation
The protein is evaluated using the analytical methods included in the quotation. Results are documented according to the agreed project deliverables.
6. Receive the protein or continue antibody development
The purified protein can be delivered for the researcher’s own workflow or transferred into an integrated monoclonal or polyclonal antibody-development project.

Potential Project Deliverables
Exact deliverables depend on the selected protein, production strategy and approved quotation.
|
Potential deliverable |
Purpose |
|
Purified recombinant protein |
Immunization, screening, affinity purification or assay development |
|
Certificate of Analysis |
Product and batch specifications |
|
Purity analysis |
Confirmation of the agreed protein-quality specification |
|
Identity report |
Confirmation of the intended protein target |
|
Endotoxin report |
Documentation for sensitive downstream applications |
|
Custom formulation |
Compatibility with immunization, storage or assay workflows |
|
Packaged aliquots or bulk material |
Support for small studies or larger projects |
|
Antibody-development results |
Tracking of an integrated protein and antibody project |
|
Project-specific QC results |
Documentation of analyses included in the quotation |

What Determines Pricing and Timeline?
Custom protein production is quoted individually because each target can require a different construct, expression and purification strategy.
Pricing generally depends on:
- Sequence length and complexity
- Construct-design requirements
- Selected expression system
- Soluble or membrane-associated format
- Required production yield
- Purity target
- Endotoxin specification
- Tag type and tag removal
- Buffer and formulation
- Quality-control requirements
- Packaging and aliquoting
- Antibody-development scope
A soluble domain expressed in a microbial system can require a different workflow from a glycosylated mammalian protein or complex membrane-associated antigen. The confirmed timeline is provided after technical feasibility review. It reflects construct preparation, protein expression, purification, quality control and any connected antibody-development stages. Buyers should include their preferred delivery date when requesting a quotation.
Information Required for a Quote
Use this checklist when submitting a project:
|
Information |
Details to provide |
|
Target |
Protein name, gene symbol or accession number |
|
Species |
Human, mouse, rat, viral or another organism |
|
Sequence |
Full sequence or required amino-acid range |
|
Construct |
Full-length, domain, extracellular region, mutant or isoform |
|
Application |
Immunization, ELISA, Western blot, flow cytometry or another use |
|
Expression host |
Preferred host or request a recommendation |
|
Tag |
Type, position and removal requirement |
|
Quantity |
Required amount and possible repeat-production needs |
|
Purity |
Requested purity target |
|
Endotoxin |
Required specification, where applicable |
|
Formulation |
Buffer, concentration and liquid or lyophilized format |
|
Quality control |
Required identity, purity, endotoxin or functional analyses |
|
Packaging |
Individual aliquots or bulk packaging |
|
Antibody scope |
Protein only, polyclonal antibody or monoclonal antibody project |
|
Timeline |
Preferred delivery date or research milestone |
If every technical specification has not yet been selected, submit the sequence, intended application and required quantity. A suitable production strategy can be recommended following review.
Submit a Project Evaluation | Contact Technical Support
Start Your Custom Protein Project
Beta LifeScience offers catalog, semi-custom and fully custom protein-production routes for antibody generation, screening and validation. Researchers can request a project-specific construct, expression host, tag, purification strategy, purity level, endotoxin specification, formulation and production scale.
Projects requiring antigen preparation and antibody generation can combine custom protein expression with monoclonal or polyclonal antibody production.
Request a Custom Protein Quote | Start an Antibody Project | Discuss Your Target
FAQs
What is the best protein antigen for antibody development?
The best antigen presents the required target epitope in a stable and relevant format. Depending on the intended application, this may be a full-length protein, extracellular domain, functional domain, mutant, isoform or specialized membrane-protein format.
Which expression system should be used for an antibody antigen?
The expression system should match the protein’s folding and modification requirements. E. coli can suit many non-glycosylated proteins, while mammalian expression may be preferred for complex extracellular proteins and glycoproteins.
Should a purification tag be removed before immunization?
Tag removal can help limit tag-specific immune responses. Another strategy is to use different tags during immunization and antibody screening. The appropriate choice depends on protein stability and the development plan.
Can custom protein production include antibody development?
Yes. Custom protein expression can be coordinated with monoclonal or polyclonal antibody production. The exact antigen, immunization, screening and final deliverables should be defined in the project quotation.
How much does custom protein production cost?
Pricing depends on sequence complexity, construct design, expression system, required yield, purity, endotoxin specification, tag removal, formulation, quality control and antibody-development scope.
How long does custom protein production take?
The timeline depends on the target, construct, expression platform, purification requirements and quality-control scope. A confirmed timeline is provided after feasibility review.
What deliverables are included?
Deliverables are defined in the approved quotation. They may include purified recombinant protein, a CoA, purity analysis, identity results, endotoxin documentation, custom formulation and project-specific quality-control reports.